AI-based software solution that analyzes 10-second normal sinus rhythm ECG data to predict atrial fibrillation risk and identify patients at potential risk for arrhythmia development. The system provides quantified risk assessment to support clinical decision-making for early detection and preventiv...
Manufactured by
DeepCardio Co. LTD.
South Korea
DeepCardio leverages AI-driven analysis of ECG (electrocardiogram) data to detect heart diseases. Founded in 2020, we have co-developed with leading medical centers. We received MFDS (Ministry of Food and Drug Safety) approval in 2024 for our AF (Atrial Fibrillation) AI-ECG solution. As we pursuing MFDS approval for solutions of CV (cardiovascular) risk and EF estimation, we are evloving into a cardiology-focused vertical AI company.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
KARDI AI Technologies s.r.o
Czech Republic · 7 relevant products
AXIS Healthcare Trading FZE
United Arab Emirates · 1 relevant product
Harvey Cardio Co., Ltd.
South Korea · 1 relevant product
32 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 62 closest product alternatives
KARDI AI Technologies s.r.o · Czech Republic
AI-based computational tool for assessing patient risk of adverse cardiac events. Integrates multiple clinical, imaging, and laboratory parameters to generate personalized risk scores. Supports evidence-based decision-making for patient management and treatment planning.
AXIS Healthcare Trading FZE · United Arab Emirates
AI-powered cardiovascular risk assessment system that analyzes patient data to identify and stratify cardiac risk factors. Integrates clinical parameters and diagnostic indicators to support evidence-based clinical decision-making and preventive cardiology interventions.
Harvey Cardio Co., Ltd. · South Korea
AI-powered computational module generating integrated cardiovascular and cerebrovascular risk assessment scores. Combines physiological data interpretation with machine learning to provide comprehensive risk profiling for clinical decision-making.
59 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products